Zimmer, Biomet Sell Off Some U.S. Assets As They Finalize A $14 Bil. Merger
This article was originally published in The Gray Sheet
Executive Summary
Zimmer Biomet is now the second-largest orthopedic device maker behind Johnson & Johnson now that the merger between the two firms is complete. The companies divested some U.S. knee, elbow and bone cement assets in conjunction with finalized the deal after having sold of some European assets earlier in the year.